Desvenlafaxine is used for: Depression.
Recorded in the NepalDoc medicine catalog for Desvenlafaxine.
Desvenlafaxine extended-release tablets are indicated for the treatment of adults with major depressive disorder (MDD).
From the U.S. FDA-approved label for Desvenlafaxine. Full label: DailyMed.
Desvenlafaxine extended-release tablets are indicated for the treatment of adults with major depressive disorder (MDD).
From the U.S. FDA-approved label for Desvenlafaxine. Full label: DailyMed.
Recommended dose: 50 mg once daily with or without food. There was no evidence that doses greater than 50 mg per day confer any additional benefit. The 25 mg per day dose is intended for a gradual reduction in dose when discontinuing treatment or dosing in severe renal and end-stage renal disease patients.
Directions from the U.S. FDA-approved label for Desvenlafaxine — your doctor or pharmacist may advise differently.
Hypersensitivity to desvenlafaxine succinate, venlafaxine hydrochloride or to any excipients in the desvenlafaxine extended-release tablets formulation. Angioedema has been reported in patients treated with desvenlafaxine extended-release tablets. The use of MAOIs intended to treat psychiatric disorders with desvenlafaxine extended-release tablets or within 7 days of stopping treatment with desvenlafaxine extended-release tablets is contraindicated because of an increased risk of serotonin syndrome.
Excerpt from the U.S. FDA-approved label for Desvenlafaxine. Talk to a pharmacist or doctor before use.
Serotonin Syndrome: Increased risk when co-administered with other serotonergic agents, but also when taken alone. If it occurs, discontinue desvenlafaxine extended-release tablets and serotonergic agents and initiate supportive treatment. Elevated Blood Pressure: Control hypertension before initiating treatment. Monitor blood pressure regularly during treatment. Increased Risk of Bleeding: Concomitant use of aspirin, NSAIDs, other antiplatelet drugs, warfarin, and other anticoagulants may increase this risk.
Warnings and precautions excerpt from the U.S. FDA-approved label for Desvenlafaxine — not a complete list. Talk to a pharmacist or doctor before use.
The following adverse reactions are discussed in greater detail in other sections of the label. Hypersensitivity Suicidal Thoughts and Behaviors in Pediatric and Young Adult Patients Serotonin Syndrome Elevated Blood Pressure Increased Risk of Bleeding Angle Closure Glaucoma Activation of Mania/Hypomania Discontinuation Syndrome Seizure Hyponatremia Interstitial Lung Disease and Eosinophilic Pneumonia Sexual Dysfunction Most…
Excerpt from the U.S. FDA-approved label for Desvenlafaxine — not a complete list. Talk to a pharmacist or doctor about side effects.
3 brands · 2 makers in the NepalDoc catalog — see the full Desvenlafaxine guide →
Store at 20° to 25°C (68° to 77°F);
Storage information from the U.S. FDA-approved label for Desvenlafaxine.
What is D-Veniz?
D-Veniz 100mg Tablet is a Desvenlafaxine medicine made by Sun Pharmaceutical Industries Ltd. It comes as 100mg Tablet.
What is D-Veniz used for?
Desvenlafaxine is used for Depression.
What is the generic name of D-Veniz?
The generic name of D-Veniz is Desvenlafaxine.
Which brands of Desvenlafaxine are available in Nepal?
3 brands of Desvenlafaxine are listed in the NepalDoc catalog, from 2 makers — including D-Veniz 200mg Tablet, Pristiq 50mg Tablet.
What are the side effects of Desvenlafaxine?
The following adverse reactions are discussed in greater detail in other sections of the label.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
